ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

2 links1 made here, not in the record2 judgments1 judge (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Made here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07716111Neoadjuvant SHR-A1811 andSHR-A1701 ± Pertuzumab forPotentiallyImmunotherapy-Sensitive GCor GEJ AdenocarcinomaThe First Affiliated Hospital Phase 2 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.DRUGSPertuzumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partnerTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pertuzumab

Made here1 judgment on this link
NCT07716111gives it, found by reading the recordPertuzumabDefined by Claude Opus 5.5Nov 3, 2026, 5:40 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 3Pertuzumabmade hereClaude Opus 5.5Background · partnerCurrent